Lilly’s $6.3B Sleep Bet Isn’t About Sleep — It’s About Owning the Next Neuroscience Platform
Eli Lilly just paid $6.3 billion upfront for Centessa Pharmaceuticals and its sleep disorder pipeline. The price looks steep...
M&A
Eli Lilly just paid $6.3 billion upfront for Centessa Pharmaceuticals and its sleep disorder pipeline. The price looks steep...